WHAT’S NEW + WHAT’S NOW +

WHAT’S NEXT

PROPELLING THE

GENERICS AND BIOSIMILARS

INDUSTRY FORWARD

NOVEMBER 7-9, 2022 | BETHESDA NORTH MARRIOTT, NORTH BETHESDA, MD

The premier scientific and regulatory event

GRx+BiosimsTM 2022 is the premier scientific and regulatory event for the U.S. generics and biosimilars industry, featuring timely programming relevant to technical, regulatory and policy professionals.

LEARN +
CONNECT

Bench scientists and technical professionals can gain insights from drug regulators to help expedite approvals and speed to market, and learn about the latest innovations and emerging technology. Policy professionals, industry professionals and regulators have the opportunity to network with others in the industry and gain a fuller understanding of how regulations affect the real world. In addition, connect with global influencers, increase your knowledge base to stay on the cutting edge and learn about best practices to enhance your organization’s overall performance.

CONNECT +
SHARE!

Join us at GRx+Biosims 2022 November 7-9, 2022. This conference offers three days of insights and ideas on issues vital to the generics and biosimilars industry. We have put together an ambitious program filled with a range of topics, discussions and views from industry experts.

We look forward to welcoming you to GRx+Biosims 2022.

Why You
Should Attend

Face-to-face engagement

Among speakers, attendees, exhibitors, and sponsors

Get Access

To the latest information about U.S. generics + biosimilars

Learn

How the generics and biosimilars industry affects patient outcomes by increasing access to medicine

Make Decisions

With more confidence by better understanding FDA’s expectations

Gain Expert Insights

On the latest regulations, guidance’s, case law and policies

One-Stop Shop

For all your regulatory and scientific needs, including CEUs and CE education

SPEAKER
HIGHLIGHTS

Sally Choe, PhD

Director, Office of Generic Drugs (OGD), CDER, FDA

Sarah Yim, M.D.

Director, Office of Generic Drugs (OGD), CDER, FDA

Gerald Dal Pan, M.D., MHS

Director, Office of Generic Drugs (OGD), CDER, FDA

Sally Choe, PhD

Director, Office of Generic Drugs (OGD), CDER, FDA

Sponsorship
Opportunities

Raise your company profile by participating in this prestigious event. Included in your sponsorship are custom branded digital assets you can use to promote your sponsorship of the event. You will also gain visibility to your brand through conference advertising prior to and during the event.

For more information regarding sponsorship levels and benefits contact Aquera Agee.

EXPO

Don’t miss out on this highly interactive and professional business environment in which industry vendors can meet generics and biosimilars industry executives. We offer our exhibitors abundant networking time with industry decision-makers.

Showcase your company at GRx+Biosims 2022

Download Coming Soon

Publication Partners

GBI

GET THE LATEST UPDATES

Receive the latest event information about key speakers, sponsorship opportunities and exhibiting.

Skip to content